We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Contract Drug Manufacturer Irisys Rapped for Repeated Quality Lapses
Contract Drug Manufacturer Irisys Rapped for Repeated Quality Lapses
FDA investigators observed several deficiencies in a March 30 to April 7 inspection of San Diego-based contract development and manufacturing organization (CDMO) Irisys, including the quality unit’s failure to document the review and approval of each batch production record.